You have great science but need to quickly
translate that into revenue.
That's where we help.
We identify and grow early biotech, medtech, and deeptech startups,
including independent innovators and university spinouts.
We bring network, technical, and commercial expertise,
and we work at-risk for equity.
We're experienced operators embedded in your company — not coaches, not investors at arm's length. We work at-risk for equity, so we only win when you do.
No cohorts. Every engagement is bespoke — we embed in your business.
No LPs, no conflicts. We invest our most scarce resource: expert time.
No hourly fees. We work at-risk for equity.
We bring network, domain knowledge, and hands-on execution — to strengthen your firm, protect your IP, and drive commercialization.
We embed in your organization to validate market opportunity and define the go-to-market strategy.
We provide or facilitate pre-angel capital to bridge the hardest financing gap in deep-tech.
We activate our network to drive revenue and position the company for institutional investment or acquisition.
Market creation, commercialization, M&A, and federal funding — translating early-stage technology into commercial strategy.
Biotech and global pharma operator — lab to market, building technical teams, and scientific portfolio management.